Partial Disposal of Shares in SkinBioTherapeutics

In brief · summary, not quotable

OptiBiotix Health plc has partially disposed of its shareholding in SkinBioTherapeutics plc, selling 7,500,000 ordinary shares for £675,000 in cash. These proceeds will be used for general working capital, extending the company's runway into the first half of 2027. Following this sale, OptiBiotix retains 5,700,000 ordinary shares in SkinBioTherapeutics, representing 2.2% of its total issued share capital.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your OPTI notes

OptiBiotix Health plc (AIM: OPTI, OTCQB: OPTBF), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes announces that it has disposed of 7,500,000 ordinary shares in SkinBioTherapeutics plc (AIM:SBTX) ("SkinBioTherapeutics"), generating cash proceeds of £675,000 which will be used for the Company's general working capital purposes and are expected to provide the Company with working capital runway into H1 2027.

Following the disposal, the Company's shareholding in SkinBioTherapeutics consists of 5,700,000 ordinary shares, representing 2.2% of the total issued share capital of SkinBioTherapeutics at the date of this announcement.

Caution regarding forward looking statements

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.